A microfluidic device for label-free, physical capture of circulating tumor cell clusters

Nature Methods

Volumn 12, Issue 7, 2015, Pages 685-691

  Sarioglu, A Fatih ^a,b   Aceto, Nicola ^a,b   Kojic, Nikola ^a   Donaldson, Maria C ^b   Zeinali, Mahnaz ^a,b   Hamza, Bashar ^a   Engstrom, Amanda ^b   Zhu, Huili ^b   Sundaresan, Tilak K ^b   Miyamoto, David T ^a,b   Luo, Xi ^b   Bardia, Aditya ^a,b   Wittner, Ben S ^b   Ramaswamy, Sridhar ^a,b   Shioda, Toshi ^b   Ting, David T ^a,b   Stott, Shannon L ^a,b   Kapur, Ravi ^a   Maheswaran, Shyamala ^a,b   Haber, Daniel A ^a,b,c,d   Toner, Mehmet ^a   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TUMOR MARKER;

ARTICLE; BLOOD SAMPLING; BREAST METASTASIS; CANCER CELL LINE; CANCER PATIENT; CANCER TISSUE; CELL ISOLATION; CELL JUNCTION; CIRCULATING TUMOR CELL; CLUSTER ANALYSIS; CLUSTER CHIP; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LAB ON A CHIP; LABELING INDEX; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MICROCHIP ANALYSIS; MICROFLUIDICS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; RNA SEQUENCE; SHEAR STRESS; BREAST TUMOR; IMMUNOHISTOCHEMISTRY; MICROFLUIDIC ANALYSIS; PATHOLOGY; PROSTATE TUMOR; SEQUENCE ANALYSIS; TUMOR CELL LINE; TUMOR EMBOLISM;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROFLUIDIC ANALYTICAL TECHNIQUES; NEOPLASTIC CELLS, CIRCULATING; PROSTATIC NEOPLASMS; SEQUENCE ANALYSIS, RNA;

EID: 84934437818     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth.3404     Document Type: Article

References (37)

1. Pantel, K., Brakenhoff, R.H. & Brandt, B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat. Rev. Cancer 8, 329-340 (2008).
2. Yu, M., Stott, S., Toner, M., Maheswaran, S. & Haber, D.A. Circulating tumor cells: approaches to isolation and characterization. J. Cell Biol. 192, 373-382 (2011).
3. Nagrath, S. et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450, 1235-1239 (2007).
4. Stott, S.L. et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc. Natl. Acad. Sci. USA 107, 18392-18397 (2010).
5. Ozkumur, E. et al. Inertial focusing for tumor antigen-dependent and-independent sorting of rare circulating tumor cells. Sci. Transl. Med. 5, 179ra47 (2013).
6. Yoon, H.J. et al. Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets. Nat. Nanotechnol. 8, 735-741 (2013).
7. Yu, M. et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339, 580-584 (2013).
8. Watanabe, S. The metastasizability of tumor cells. Cancer 7, 215-223 (1954).
9. Fidler, I.J. The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur. J. Cancer 9, 223-227 (1973).
10. Yu, M. et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 487, 510-513 (2012).
11. Brandt, B. et al. Isolation of prostate-derived single cells and cell clusters from human peripheral blood. Cancer Res. 56, 4556-4561 (1996).
12. Molnar, B., Ladanyi, A., Tanko, L., Sréter, L. & Tulassay, Z. Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. Clin. Cancer Res. 7, 4080-4085 (2001).
13. Cho, E.H. et al. Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys. Biol. 9, 016001 (2012).
14. Krebs, M.G. et al. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and-independent approaches. J. Thorac. Oncol. 7, 306-315 (2012).
15. Hou, H.W. et al. Isolation and retrieval of circulating tumor cells using centrifugal forces. Sci. Rep. 3, 1259 (2013).
16. Duda, D.G. et al. Malignant cells facilitate lung metastasis by bringing their own soil. Proc. Natl. Acad. Sci. USA 107, 21677-21682 (2010).
17. Hou, J.M. et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J. Clin. Oncol. 30, 525-532 (2012).
18. Aceto, N. et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158, 1110-1122 (2014).
19. Vona, G. et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am. J. Pathol. 156, 57-63 (2000).
20. Coumans, F.A.W., van Dalum, G., Beck, M. & Terstappen, L.W.M.M. Filtration parameters influencing circulating tumor cell enrichment from whole blood. PLoS ONE 8, e61774 (2013).
21. Yu, M. et al. A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression. Genes Dev. 23, 1737-1742 (2009).
22. Rico, F., Chu, C., Abdulreda, M.H., Qin, Y. & Moy, V.T. Temperature modulation of integrin-mediated cell adhesion. Biophys. J. 99, 1387-1396 (2010).
23. Kattlove, H.E. & Alexander, B. The effect of cold on platelets. I. Cold-induced platelet aggregation. Blood 38, 39-48 (1971).
24. Shah, A.M. et al. Biopolymer system for cell recovery from microfluidic cell capture devices. Anal. Chem. 84, 3682-3688 (2012).
25. Luo, X. et al. Isolation and molecular characterization of circulating melanoma cells. Cell Rep. 7, 645-653 (2014).
26. Miyamoto, D.T. et al. Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer. Cancer Discov. 2, 995-1003 (2012).
27. Inwald, E.C. et al. Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res. Treat. 139, 539-552 (2013).
28. Labelle, M., Begum, S. & Hynes, R.O. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20, 576-590 (2011).
29. Kuvaja, P. et al. Tumor tissue inhibitor of metalloproteinases-1 (TIMP-1) in hormone-independent breast cancer might originate in stromal cells, and improves stratification of prognosis together with nodal status. Exp. Cell Res. 318, 1094-1103 (2012).
30. Hekmat, O. et al. TIMP-1 increases expression and phosphorylation of proteins associated with drug resistance in breast cancer cells. J. Proteome Res. 12, 4136-4151 (2013).
31. Würtz, S.O., Schrohl, A.-S., Mouridsen, H. & Brünner, N. TIMP-1 as a tumor marker in breast cancer-an update. Acta Oncol. 47, 580-590 (2008).
32. Würtz, S. et al. Tissue inhibitor of metalloproteinases-1 in breast cancer. Endocr. Relat. Cancer 12, 215-227 (2005).
33. Talasaz, A.H. et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc. Natl. Acad. Sci. USA 106, 3970-3975 (2009).
34. Qian, B.-Z. & Pollard, J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51 (2010).
35. Wyckoff, J.B. et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 67, 2649-2656 (2007).
36. Pardoll, D.M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252-264 (2012).
37. Kojić, N. et al. A 3-D model of ligand transport in a deforming extracellular space. Biophys. J. 99, 3517-3525 (2010).